Institutional members access full text with Ovid®

Share this article on:

Suboptimal Prenatal Syphilis Testing Among Commercially Insured Women in the United States, 2013

Neblett Fanfair, Robyn MD, MPH; Tao, Guoyu PhD; Owusu-Edusei, Kwame PhD; Gift, Thomas L. PhD; Bernstein, Kyle T. PhD

Sexually Transmitted Diseases: April 2017 - Volume 44 - Issue 4 - p 219–221
doi: 10.1097/OLQ.0000000000000569
Note

Abstract: United States surveillance data demonstrate that congenital syphilis cases are increasing. We performed an analysis of commercially insured pregnant females using MarketSan to determine syphilis screening rates at different prenatal stages; 85% of pregnant women in this population had a syphilis test performed at least once during the prenatal period.

Prenatal syphilis screening is key to identifying women with syphilis to initiate treatment, and prevent adverse pregnancy outcomes. In this commercially insured population, only 85% received at least 1 syphilis test during the prenatal period.

From the Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA

Conflict of interest: None declared.

Correspondence: Robyn Neblett Fanfair, MD, MPH, Centers for Disease Control and Prevention, Atlanta, GA. E-mail: iyo5@cdc.gov.

Received for publication May 11, 2016, and accepted November 9, 2016.

© Copyright 2017 American Sexually Transmitted Diseases Association